Loading content...
Loading comments...
CARBIDOPA, LEVODOPA AND ENTACAPONE
Wed Oct 22 2025
- views
Reason for Recall
Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).
Manufacturers
| Drug | Manufacturer |
|---|---|
| CARBIDOPA, LEVODOPA AND ENTACAPONE | Rising Pharma Holdings, Inc. |
Number of affected units
2,064 100-count bottles
Distribution pattern
Distributed Nationwide in the USA
UPCs
| UPC |
|---|
| 0316571689019 |
| 0316571692019 |
| 0316571694013 |
| 0316571690015 |
| 0316571691012 |
| 0316571693016 |
Package NDCs
| NDC |
|---|
| 16571-689-01 |
| 16571-690-01 |
| 16571-691-01 |
| 16571-692-01 |
| 16571-693-01 |
| 16571-694-01 |
Comments (-)
Must be signed in to post a comment.